A502 Endoscopic Gastric Botulinum as a Treatment for Obesity – Practical Aspects and Outcomes

Several small studies were published evaluating the effect of Endoscopic Gastric Botulinum Toxin type A (EGB) for the treatment of obesity giving conflicting results. Botulinum Toxin type A (BT-A) has a powerful inhibiting effect of long duration on the muscular contractions of smooth and striated muscles. This property has been used in the treatment of digestive illnesses characterized by muscular spasm, particularly achalasia and anal fissure
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Source Type: research